NCT05082753View on ClinicalTrials.gov

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 19, 2020

Primary Completion Date

December 21, 2020

Study Completion Date

December 21, 2020

Conditions

Anthelmintic Agent

Interventions

DRUG

Ivermectin tablets (3 mg Ivermectin)

Two Ivermectin tablets were administered orally.

DRUG

Stromectol ® tablets

Two Ivermectin tablets were administered orally.

Trial Locations (1)

Unknown

ACDIMA Biocenter, Amman

All Listed Sponsors

lead

Humanis Saglık Anonim Sirketi

INDUSTRY

NCT05082753 - Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter